At $57.54 versus $143.16 fair value, Mondelez offers Oreos and Cadbury at 40 cents on the dollar.
This framework sees a predictable earnings machine with strong brands trading at a 59.8% discount to fair value, but questions whether margin compression signals moat erosion.
If you bought this entire business today, would what it earns justify what you paid?
Applying this lens reveals a remarkable disconnect — the market prices MDLZ as if growth has stopped entirely. For a permanent owner, buying at 59.8% below fair value with consistent cash generation offers substantial margin of safety despite the premium to treasuries.
Does this company have a durable competitive advantage that protects returns?
This framework identifies a puzzling moat — clear pricing power exists (94.3% inflation correlation) yet margins compress to decade lows. The brand strength remains but cost pressures are overwhelming pricing, suggesting the moat faces unprecedented tests.
Are the earnings predictable and growing?
Through this lens, MDLZ demonstrates exactly the earnings predictability this framework values — beating estimates 94.9% of the time. The cash flow volatility concerns, but the earnings themselves prove remarkably consistent quarter after quarter.
How much cash does an owner actually get to keep after maintaining the business?
This framework finds exceptional cash generation — owners keep real money with minimal dilution. The zero SBC anomaly actually enhances owner earnings, and the high FCF conversion demonstrates a business requiring little capital to maintain.
Are managers acting as owners or agents?
This lens reveals mixed stewardship — insiders demonstrate owner-like conviction by buying during the drawdown, but the buyback program destroyed $2.9B in shareholder value. The framework sees managers who believe in the business but allocate capital poorly.
This framework sees a collection of powerful snack brands generating predictable earnings and exceptional cash flow, trading at a remarkable 59.8% discount to fair value. The margin compression and negative operating leverage raise concerns about the moat's durability, but the price offers substantial margin of safety for patient capital. Would you rather own treasuries at 4.33% or these beloved brands at 40 cents on the dollar?
This analysis applies Warren Buffett's published investment framework to publicly available financial data. It is not authored by, endorsed by, or affiliated with Warren Buffett. Educational purposes only. Not financial advice.